Truong Phu Xanh

Truong Phu Xanh is a Vietnamese private company engaged in seafood processing and export rather than a life science, biotech, pharma, or healthcare business. Public trade and regulatory sources indicate the company exports fish and seafood products including yellowfin tuna, mahi-mahi, and octopus. The company became notable in U.S. regulatory records after FDA actions tied to histamine and decomposition concerns in imported tuna products in 2019, and it has appeared on FDA import alert listings. Available business registry and trade sources place the company in central Vietnam and indicate it remains an operating commercial food products company.